{"DataElement":{"publicId":"7431109","version":"1","preferredName":"Disposition Domain Occurrence CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator","preferredDefinition":"An indication whether the pre-specified disposition event or the group of disposition events occurred when the occurrence of the specific event or group of events is solicited.","longName":"DS_DSOCCUR","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7431100","version":"1","preferredName":"Disposition Domain Occurrence","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition._An instance of something happening, such as an event or incident.","longName":"2859364v1.0:2234856v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2859364","version":"1","preferredName":"Disposition Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition.","longName":"C49576","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disposition Domain","conceptCode":"C49576","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"667C7B15-C9BA-53A6-E040-BB89AD43558C","latestVersionIndicator":"Yes","beginDate":"2009-04-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-04-01","modifiedBy":"ONEDATA","dateModified":"2009-04-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2513925","version":"1","preferredName":"Activity","preferredDefinition":"An action taken in pursuit of an objective; the state of being active.","longName":"C43431","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8A8A1E-77BA-4685-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"CURTIST","dateCreated":"2006-08-21","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFFDCC24-B2DD-29F6-E053-4EBD850AC288","latestVersionIndicator":"Yes","beginDate":"2020-09-23","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-23","modifiedBy":"SETRAKIN","dateModified":"2020-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6343337","version":"1","preferredName":"CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator","preferredDefinition":"Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"NY","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6F9FC413-3EDC-2FFB-E053-F662850AA144","beginDate":"2018-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-27","modifiedBy":"ONEDATA","dateModified":"2018-06-27","deletedIndicator":"No"},{"value":"Y","valueDescription":"Yes","ValueMeaning":{"publicId":"5676138","version":"1","preferredName":"Yes","longName":"5676138","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49204933-EF64-01C8-E053-F662850A7582","latestVersionIndicator":"Yes","beginDate":"2017-02-22","endDate":null,"createdBy":"ANDERSONR","dateCreated":"2017-02-22","modifiedBy":"MMADDINENI","dateModified":"2024-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6F9FC413-3EF1-2FFB-E053-F662850AA144","beginDate":"2018-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-27","modifiedBy":"ONEDATA","dateModified":"2018-06-27","deletedIndicator":"No"},{"value":"NA","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5043360","version":"1","preferredName":"Not Applicable","longName":"5043360","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2421E11B-65A6-151D-E050-BB89AD4378BB","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73F48F3A-1DF1-2954-E053-F662850A5947","beginDate":"2018-06-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","deletedIndicator":"No"},{"value":"U","valueDescription":"Unknown","ValueMeaning":{"publicId":"3104212","version":"1","preferredName":"Unknown","longName":"3104212v1.00","preferredDefinition":"Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-06F4-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":"Concept annotated for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73F48F3A-1DFD-2954-E053-F662850A5947","beginDate":"2018-06-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6343336","version":"1","preferredName":"CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator","preferredDefinition":"A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C66742:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDISC SDTM Yes No Unknown or Not Applicable Response Terminology","conceptCode":"C66742","definition":"Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F9FC413-3E96-2FFB-E053-F662850AA144","latestVersionIndicator":"Yes","beginDate":"2018-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-27","modifiedBy":"ONEDATA","dateModified":"2018-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6F9FC413-3EA7-2FFB-E053-F662850AA144","latestVersionIndicator":"Yes","beginDate":"2018-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-06-27","modifiedBy":"ZHWENDY","dateModified":"2023-12-12","changeDescription":"Elevated to Standard per governance approval by RA. 2021-6-9 ak  12/18/18 TT released/MC. 8-21-18 edit to PVs/CDISC revised submission values; tt.  Created as part of CDISC mapping task. 6.27.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"DS_DSOCCUR_PK","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_TIS_BNK","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_TIS_IHC","type":"COG Form Element","context":"COG"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"DS_DSOCCUR_BNK","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_BMCSFPB","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_CTDNA","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_OTH","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_VXLD_CALLB","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_CTC","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_X1","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_BMPB_GENE","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_BMPBIMUN","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_CYKAN","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_PHMDYN","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_BXTIS","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_BIOBNK_SLPUNKS","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_QOL","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_BIOBNK","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_TISBMBLDBIOMK","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_TIS","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_BLD","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_BM","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_MSAS","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_PEDSQL","type":"COG Form Element","context":"COG"},{"name":"DS_DSOCCUR_HOUSEDSVY","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Patient has consented to circulating tumor cells and circulating tumor DNA","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Did patient sign consent for Post-VXLD treatment?","url":null,"context":"COG"},{"name":"[Did/Does] the subject have [","type":"Preferred Question Text","description":"[Did/Does] the subject have [--TERM] (after/before [study-specific time frame] )?; Is the [pre-specified medical occurring]?","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Did patient consent to have bone marrow, peripheral blood, and CSF samples collected and studied for Correlative Immunobiology studies?","url":null,"context":"COG"},{"name":"COG CRF Text 7","type":"Alternate Question Text","description":"Did patient consent to optional sample collections for laboratory studies?","url":null,"context":"COG"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Patient has consented to circulating tumor DNA","url":null,"context":"COG"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Was consent given for patient's tissue and/or blood samples to be kept (banked) for use in research to learn about, prevent, or treat cancer or other health problems (for example: diabetes, Alzheimer's disease, or heart disease)?","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Did patient consent to let researchers bank specimens (such as tumor, blood or bone marrow) for future use to learn about, prevent or treat cancer?","url":null,"context":"COG"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"Patient has consented to archival tumor tissue for biobanking","url":null,"context":"COG"},{"name":"COG CRF Text 10","type":"Alternate Question Text","description":"Did patient consent to the tumor tissue studies?","url":null,"context":"COG"},{"name":"COG CRF Text 11","type":"Alternate Question Text","description":"Did patient consent to the archival tumor tissue studies?","url":null,"context":"COG"},{"name":"COG CRF Text 13","type":"Alternate Question Text","description":"Patient has consented to archival tumor tissue for immunohistochemistry","url":null,"context":"COG"},{"name":"COG CRF Text 12","type":"Alternate Question Text","description":"Did patient consent to blood samples for pharmacokinetic tests?","url":null,"context":"COG"},{"name":"COG CRF Text 14","type":"Alternate Question Text","description":"Did patient consent to tumor tissue for Whole Genome Sequencing (WGS)?","url":null,"context":"COG"},{"name":"COG CRF Text 15","type":"Alternate Question Text","description":"Did patient consent to archival tumor tissue for Immunohistochemistry: PGBD5 and R-Loops?","url":null,"context":"COG"},{"name":"COG CRF Text 16","type":"Alternate Question Text","description":"Did patient consent to tumor tissue for Immunohistochemistry: pH2AX, pKAP1 and pATR?","url":null,"context":"COG"},{"name":"COG CRF Text 17","type":"Alternate Question Text","description":"Did patient consent to peripheral blood samples for ctDNA for ALT?","url":null,"context":"COG"},{"name":"COG CRF Text 18","type":"Alternate Question Text","description":"Did patient consent to optional blood, bone marrow, and cerebral spinal fluid to see if genetic changes can be used to predict how a subject will respond to therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 19","type":"Alternate Question Text","description":"Did patient consent to collect leftover samples for banking for use in research to learn about, prevent, or treat cancer or other health problems, for example: diabetes, Alzheimer's disease, or heart disease?","url":null,"context":"COG"},{"name":"COG CRF Text 9","type":"Alternate Question Text","description":"Did patient consent to optional blood collection to see if genetic changes can be used to predict how a subject will respond to therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 20","type":"Alternate Question Text","description":"Did the patient/parent consent to participate in HRQOL studies?","url":null,"context":"COG"},{"name":"COG CRF TEXT 21","type":"Alternate Question Text","description":"Did patient consent to the indicated optional study?","url":null,"context":"COG"},{"name":"COG CRF Text 22","type":"Alternate Question Text","description":"Did patient consent to blood samples for additional, optional pharmacokinetic tests?","url":null,"context":"COG"},{"name":"COG CRF Text 23","type":"Alternate Question Text","description":"Did patient consent to let researchers bank specimens (such as tumor, blood or bone marrow) for future use to learn about, prevent or treat cancer?","url":null,"context":"COG"},{"name":"COG CRF Text 24","type":"Alternate Question Text","description":"Did patient consent to have bone marrow and/or blood sent to a COG laboratory to study if genetic changes in the leukemia cells can be used to predict how a subject will respond to therapy using different testing methods?","url":null,"context":"COG"},{"name":"COG CRF Text 25","type":"Alternate Question Text","description":"Did patient consent to have their bone marrow and/or blood sent to a COG laboratory to study how the immune system responds to the treatment on this study?","url":null,"context":"COG"},{"name":"COG CRF Text 26","type":"Alternate Question Text","description":"Did patient consent to have their blood and/or spinal fluid sent to a COG laboratory to measure the levels of imatinib and correlate with how leukemia cells respond to imatinib treatment?","url":null,"context":"COG"},{"name":"COG CRF Text 27","type":"Alternate Question Text","description":"Did patient agree to participate in the PK tests to measure the amount of tovorafenib (DAY101) in the blood during tovorafenib therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 28","type":"Alternate Question Text","description":"Did patient consent to blood samples for cytokine analysis?","url":null,"context":"COG"},{"name":"COG CRF Text 29","type":"Alternate Question Text","description":"Did patient consent to pharmacodynamic studies?","url":null,"context":"COG"},{"name":"COG CRF Text 30","type":"Alternate Question Text","description":"Did patient consent to biopsy tumor tissue submission?","url":null,"context":"COG"},{"name":"COG CRF Text 31","type":"Alternate Question Text","description":"Did patient consent to circulating tumor DNA?","url":null,"context":"COG"},{"name":"COG CRF Text 32","type":"Alternate Question Text","description":"Did patient consent to have their blood and/or spinal fluid sent to a COG laboratory to measure the levels of dasatinib and correlate with how leukemia cells respond to dasatinib treatment?","url":null,"context":"COG"},{"name":"COG CRF Text 33","type":"Alternate Question Text","description":"Did the patient/parent consent to participate in sociodemographic studies?","url":null,"context":"COG"},{"name":"COG CRF Text 34","type":"Alternate Question Text","description":"Has patient consented to complete the questionnaires for Patient Reported Outcomes and Quality of Life?","url":null,"context":"COG"},{"name":"COG CRF Text 35","type":"Alternate Question Text","description":"Has patient consented to have samples kept (banked) for use in research to learn about, prevent, or treat cancer or health problems (for example: diabetes, Alzheimer's disease, or heart disease)?","url":null,"context":"COG"},{"name":"COG CRF TEXT 36","type":"Alternate Question Text","description":"Did patient consent for use of tumor tissue and tumor tissue slides to be studied to see if biomarkers, genetic changes, and immune cells can be used to predict how a subject will respond to therapy?","url":null,"context":"COG"},{"name":"COG CRF TEXT 37","type":"Alternate Question Text","description":"Did patient consent for use of blood to be studied to see if biomarkers and immune response can be used to predict how a subject will respond to therapy?","url":null,"context":"COG"},{"name":"COG CRF TEXT 38","type":"Alternate Question Text","description":"Did patient consent to have any leftover tissue, tissue slides, blood, and/or bone marrow kept (banked) for use in research to learn about, prevent, or treat cancer or other health problems (for example: diabetes, Alzheimer's disease, or heart disease)?","url":null,"context":"COG"},{"name":"COG CRF TEXT 39","type":"Alternate Question Text","description":"Did the patient consent to complete the PedsQL surveys?","url":null,"context":"COG"},{"name":"COG CRF TEXT 40","type":"Alternate Question Text","description":"Did the patient consent to the Household Survey?","url":null,"context":"COG"},{"name":"COG CRF Text 41","type":"Alternate Question Text","description":"Did patient consent to have leftover tumor tissue, tumor tissue slides, bone marrow, and peripheral blood from diagnosis collected through APEC14B1 sent to a COG laboratory to be studied to see if biomarkers can be used to predict how a subject will respond to therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 42","type":"Alternate Question Text","description":"Did patient consent for use of their bone marrow to be studied to see if certain biomarkers can be used to predict how a subject will respond to therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 43","type":"Alternate Question Text","description":"Did the patient consent to the Memorial Symptom Assessment Scale (MSAS) surveys?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFFCF37C-F9D2-084C-E053-4EBD850ACB9C","latestVersionIndicator":"Yes","beginDate":"2020-09-23","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-23","modifiedBy":"MMADDINENI","dateModified":"2024-02-16","changeDescription":null,"administrativeNotes":"2023.10.12 AQT added per ticket request CADSR0002943. ak 8/4/23 Added Alt SN per ticket #CADSR0002685_mmt\r\n2023.6.29 AQT added per ticket request CADSR0002564. ak 2023.5.30 Alt Name/Alt SN added per ticket request CADSR0002435.  ak 2023.3.13 Alt SN/AQT added per ticket request CADSR0002152. ak  2023.3.9 Alt SN added per ticket request CADSR0002149. ak 2023.1.19 AQT and Alt SN added per ticket request CADSR0001936. ak; 10/722 added AQT for COG cjl;","unresolvedIssues":null,"deletedIndicator":"No"}}